Medibio Limited (MEB, formerly BioProspect Limited) is a medical technology company developing a new objective test to assist in the diagnosis of depression, other mental health disorders and chronic stress. This tests utilise circadian heart rate variability. The technology is based on the scientific finding that circadian heart rate variability is a sensitive measure for depression and other mental health disorders and chronic stress
Medibio Limited operators in Health Care sector and under industry of Health Care Technology. The company website is: http://www.medibio.com.au.
You can also check out dividend history for similar stocks in the same sector as follows:
MEB Dividend Dates
Please click the table header to sort the data.
No Dividend Dates Found